News
HQH
23.32
-1.14%
-0.27
abrdn Healthcare Investors declares $0.66 dividend
Seeking Alpha · 3d ago
Press Release: Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
Dow Jones · 4d ago
Press Release: Certain Aberdeen Investments U.S. -2-
Dow Jones · 4d ago
Weekly Report: what happened at HQH last week (0803-0807)?
Weekly Report · 5d ago
HQH: After Biotech's Breakout Year, This Healthcare CEF Still Trades Below NAV; Buy
Seeking Alpha · 08/07 21:58
2 Lower-Risk Fat Dividends You Can't Ignore
Seeking Alpha · 08/03 11:35
Weekly Report: what happened at HQH last week (0727-0731)?
Weekly Report · 08/03 09:51
Weekly Report: what happened at HQH last week (0720-0724)?
Weekly Report · 07/27 09:54
Establishing A High-Yield Portfolio For Any Economic Conditions
Seeking Alpha · 07/20 11:35
Weekly Report: what happened at HQH last week (0713-0717)?
Weekly Report · 07/20 09:52
Weekly Report: what happened at HQH last week (0706-0710)?
Weekly Report · 07/13 09:53
Weekly Report: what happened at HQH last week (0629-0703)?
Weekly Report · 07/06 09:55
THQ: A Solid Healthcare Fund For 2026
Seeking Alpha · 07/03 15:01
Press Release: Aberdeen Investments U.S. -2-
Dow Jones · 06/30 20:17
Press Release: Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details
Dow Jones · 06/30 20:17
Weekly Report: what happened at HQH last week (0622-0626)?
Weekly Report · 06/29 09:52
Ride The Silver Tsunami With Big Dividends; Yields +8%
Seeking Alpha · 06/23 11:35
Weekly Report: what happened at HQH last week (0615-0619)?
Weekly Report · 06/22 09:58
Weekly Report: what happened at HQH last week (0608-0612)?
Weekly Report · 06/15 09:59
Weekly Report: what happened at HQH last week (0601-0605)?
Weekly Report · 06/08 09:56
More
Webull provides a variety of real-time HQH stock news. You can receive the latest news about abrdn Healthcare Investors through multiple platforms. This information may help you make smarter investment decisions.
About HQH
Tekla Life Sciences Investors (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in the United States and foreign companies in the life sciences industry, including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies, agriculture, and environmental management. The Fund invests primarily in securities of public and private companies, which have potential for above-average growth. The Fund may invest up to 20% of its net assets in securities of foreign issuers, located primarily in Western Europe, Canada and Japan, and securities of the United States issuers that are traded primarily in foreign markets. The Fund's investment advisor is Tekla Capital Management LLC.